Impact of ribavirin dose reduction during treatment in chronic hepatitis C genotype 1 patients.
10.3350/cmh.2012.18.3.268
- Author:
Woo Jin CHUNG
1
Author Information
1. Department of Internal Medicine, Keimyung University School of Medicine, Daegu, Korea. chung50@dsmc.or.kr
- Publication Type:Editorial ; Comment
- Keywords:
Chronic hepatitis C;
Genotype 1;
Ribavirin
- MeSH:
Antiviral Agents/*therapeutic use;
Female;
Hepatitis C, Chronic/*drug therapy;
Humans;
Interferon-alpha/*therapeutic use;
Male;
Polyethylene Glycols/*therapeutic use;
Recombinant Proteins/therapeutic use;
Ribavirin/*therapeutic use
- From:Clinical and Molecular Hepatology
2012;18(3):268-271
- CountryRepublic of Korea
- Language:English
-
Abstract:
No abstract available.
